Your browser doesn't support javascript.
Cardiovascular manifestations secondary to COVID-19: A narrative review.
Fauvel, C; Trimaille, A; Weizman, O; Pezel, T; Mika, D; Waldmann, V; Cohen, A; Bonnet, G.
  • Fauvel C; Cardiology Department, Rouen University Hospital, Rouen 76000, France; Division of Cardiovascular Medicine, Wexner Medical Center, The Ohio State University, 410 West 10th Avenue, Columbus, OH 43210, USA. Electronic address: charles.fauvelccf@gmail.com.
  • Trimaille A; Department of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg 67000, France.
  • Weizman O; Cardiology Department, Institut Lorrain du Cœur et des Vaisseaux, CHU de Nancy, 54500, France.
  • Pezel T; Cardiology Department, Lariboisière Hospital, AP-HP, Université de Paris, Paris 75010, France.
  • Mika D; Paris-Saclay University, Inserm, UMR-S 1180, Châtenay-Malabry 92296, France.
  • Waldmann V; Cardiology Department, Hôpital Européen Georges Pompidou, Université de Paris, Paris 75015, France.
  • Cohen A; Department of Cardiology, Saint Antoine and Tenon Hospital, AP-HP, INSERM UMRS-ICAN 1166 and Sorbonne University, Paris, France.
  • Bonnet G; Université de Bordeaux, 33000, France; Service Médico-Chirurgicale de Valvulopathies et Cardiomyopathies, Hôpital Cardiologique Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac 33600, France.
Respir Med Res ; 81: 100904, 2022 May.
Article in English | MEDLINE | ID: covidwho-1900123
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung damage and respiratory symptoms, the involvement of the cardiovascular system largely explains COVID-19 morbimortality. In this review, we emphasize that cardiovascular involvement is common and is associated with a worse prognosis, and that earlier detection by physicians should lead to better management. First, direct cardiac involvement will be discussed, in the form of COVID-19 myocarditis, then secondary cardiac involvement, such as myocardial injury, myocardial infarction and arrhythmias, will be considered. Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Prognostic study / Reviews Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Respir Med Res Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Prognostic study / Reviews Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Respir Med Res Year: 2022 Document Type: Article